Lexicon Pharmaceuticals (LXRX) FCF Margin (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported FCF Margin of 69.8% for Q1 2026, up 339913.0% year-over-year from N/an in Q1 2025, and up 77.75% quarter-over-quarter from 313.73% in Q4 2025.
Lexicon Pharmaceuticals (LXRX) FCF Margin (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 16 years of FCF Margin data on file, last reported at 69.8% in Q1 2026.
- FCF Margin for Q1 2026 came in at 69.8%, up 339913.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 55.72% (up 48399.0% YoY), and the FY2025 annual result was 136.24%, up 44229.0% from the prior year.
- FCF Margin improved to 69.8% in Q1 2026 per LXRX's latest filing, from 313.73% in the prior quarter.
- Over five years, FCF Margin peaked at 58.87% in Q2 2025 and troughed at 25741.98% in Q3 2023.
- A 4-year average of 4961.77% and a median of 3021.92% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin jumped 2266049 bps in 2024, then slumped 23101 bps in 2025.
- A 4-year view of FCF Margin shows it stood at 6598.96% in 2023, then soared by 99 bps to 82.72% in 2024, then plunged by 279 bps to 313.73% in 2025, then soared by 78 bps to 69.8% in 2026.
- Business Quant data shows LXRX's FCF Margin at 69.8% in Q1 2026, 313.73% in Q4 2025, and 168.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | -69.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.80% |
| Dec 31, 2025 | -313.73% |
| Sep 30, 2025 | -168.05% |
| Jun 30, 2025 | 58.87% |
| Mar 31, 2025 | -3,468.94% |
| Dec 31, 2024 | -82.72% |
| Sep 30, 2024 | -3,081.49% |
| Jun 30, 2024 | -2,962.36% |
| Mar 31, 2024 | -5,043.92% |
| Dec 31, 2023 | -6,598.96% |
| Sep 30, 2023 | -25,741.98% |
| Jun 30, 2023 | -12,068.14% |
| Dec 31, 2021 | 8,046.13% |
| Jun 30, 2021 | -9,755.13% |
| Mar 31, 2021 | -93,322.22% |
| Dec 31, 2020 | 144.31% |
| Jun 30, 2020 | -185,192.00% |
| Mar 31, 2020 | -275.71% |
| Dec 31, 2019 | -279.26% |
| Sep 30, 2019 | 64.76% |